Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

(a) On August 10, 2009, Richard E. Davis, Chief Operating Officer and Chief Financial Officer of NMT Medical, Inc. (the "Company") received a telephone call from a NASDAQ Stock Market ("NASDAQ") listing analyst notifying the Company that it is not in compliance with the filing requirements for continued listing set forth in Marketplace Rule 5450(b)(1)(A) due to the fact that the Company's stockholders' equity is less than $10 million. In response to this communication, the Company voluntarily filed an application to list its common stock on the NASDAQ Capital Market rather than the NASDAQ Global Market. The application was approved on August 10, 2009 and the Company's securities will be transferred to the NASDAQ Capital Market at the opening of business on August 12, 2009.

A copy of the press release announcing the transfer of the Company's securities from the NASDAQ Global Market to the NASDAQ Capital Market is attached hereto as Exhibit 99.1.